Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Ferrero

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Bulletin Du Cancer|June 4, 2005
[Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies]Jean-Marc Ferrero
Bulletin Du Cancer|March 30, 2004
[Docetaxel and prostate cancer]Jean-Marc Ferrero
Critical Reviews in Oncology/Hematology|November 22, 2011
New perspectives in the treatment of metastatic renal cell carcinomaJérôme Barrière, Benjamin Hoch, Jean-Marc Ferrero
JAMA Oncology|November 6, 2015
Trastuzumab and Cardiac Outcomes in Breast Cancer: A Story We Know by Heart?Gérard Milano, Emmanuel Chamorey, Jean-Marc Ferrero
Cancers|August 14, 2025
De-Escalating Anticancer Treatment: Watch Your StepJean-Marc Ferrero, Rym Bouriga, Jocelyn Gal, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
PROTACs and Glues: Striking Perspectives for Engineering Cancer Therapy À La CarteJean-Marc Ferrero, Jocelyn Gal, Baharia Mograbi, et al.
Bulletin Du Cancer|March 3, 2012
[Risk of cancer in patients following chronic dialysis and kidney graft]Nicolas Janus, Vincent Launay-Vacher, Jean-Marc Ferrero, et al.
Current Drug Targets|November 15, 2014
Trastuzumab-induced cardiotoxicity: is it a personalized risk?Gerard A Milano, Emilie Serres, Jean-Marc Ferrero, et al.
Cancers|December 11, 2025
Rethinking EPO: A Paradigm Shift in Oncology?Jean-Marc Ferrero, Baharia Mograbi, Rym Bouriga, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patientsAdel Courdi, Emmanuel Chamorey, Jean-Marc Ferrero, et al.
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Bulletin Du Cancer|June 4, 2005
[Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies]Jean-Marc Ferrero
Bulletin Du Cancer|March 30, 2004
[Docetaxel and prostate cancer]Jean-Marc Ferrero
Critical Reviews in Oncology/Hematology|November 22, 2011
New perspectives in the treatment of metastatic renal cell carcinomaJérôme Barrière, Benjamin Hoch, Jean-Marc Ferrero
JAMA Oncology|November 6, 2015
Trastuzumab and Cardiac Outcomes in Breast Cancer: A Story We Know by Heart?Gérard Milano, Emmanuel Chamorey, Jean-Marc Ferrero
Cancers|August 14, 2025
De-Escalating Anticancer Treatment: Watch Your StepJean-Marc Ferrero, Rym Bouriga, Jocelyn Gal, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
PROTACs and Glues: Striking Perspectives for Engineering Cancer Therapy À La CarteJean-Marc Ferrero, Jocelyn Gal, Baharia Mograbi, et al.
Bulletin Du Cancer|March 3, 2012
[Risk of cancer in patients following chronic dialysis and kidney graft]Nicolas Janus, Vincent Launay-Vacher, Jean-Marc Ferrero, et al.
Current Drug Targets|November 15, 2014
Trastuzumab-induced cardiotoxicity: is it a personalized risk?Gerard A Milano, Emilie Serres, Jean-Marc Ferrero, et al.
Cancers|December 11, 2025
Rethinking EPO: A Paradigm Shift in Oncology?Jean-Marc Ferrero, Baharia Mograbi, Rym Bouriga, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patientsAdel Courdi, Emmanuel Chamorey, Jean-Marc Ferrero, et al.
Pageof 17